EGFR and head and neck squamous cell carcinoma: Inhibition of xCT with chemical drug sulfasalazine induces apoptosis in CD44v-positive HNSCC cells in murine xenograft models and sensitizes tumor cells to the epidermal growth factor receptor (EGFR)-targeted therapy with cetuximab (147).